Cargando…

Prioritising the development of severity distributions in burden of disease studies for countries in the European region

Severity distributions are a means of summarising the range of health loss suffered to disease which enables estimates of disease occurrence to be paired with disability weights to estimate Years Lost to Disability (YLD) in burden of disease studies. There is a lack of current data exploring severit...

Descripción completa

Detalles Bibliográficos
Autores principales: Wyper, Grant M. A., Grant, Ian, Fletcher, Eilidh, Chalmers, Neil, McCartney, Gerry, Stockton, Diane L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6950931/
https://www.ncbi.nlm.nih.gov/pubmed/31921418
http://dx.doi.org/10.1186/s13690-019-0385-6
_version_ 1783486184570224640
author Wyper, Grant M. A.
Grant, Ian
Fletcher, Eilidh
Chalmers, Neil
McCartney, Gerry
Stockton, Diane L.
author_facet Wyper, Grant M. A.
Grant, Ian
Fletcher, Eilidh
Chalmers, Neil
McCartney, Gerry
Stockton, Diane L.
author_sort Wyper, Grant M. A.
collection PubMed
description Severity distributions are a means of summarising the range of health loss suffered to disease which enables estimates of disease occurrence to be paired with disability weights to estimate Years Lost to Disability (YLD) in burden of disease studies. There is a lack of current data exploring severity distributions, which has led to the Global Burden of Disease (GBD) study relying on using the same severity distributions across countries and regions across the world. This is also largely true for some national studies, although there are exceptions. Recent evidence has raised concerns that severity distributions are unlikely to be generalisable as major differences arise when using country-specific data to develop severity distributions. These issues raise uncertainties over interpreting YLD estimates, particularly if they are being used to develop and influence policies and to determine priorities across diseases and populations. It is clear that GBD researchers and those carrying out national studies need to work towards ensuring that estimates are based upon country-specific data, and, if possible, that the impact of assumptions are fully tested and understood. There is a lack of strategy about if, where, and how, this could be achieved, particularly around how efforts should be prioritised. This commentary advocates and presents a possible strategic approach to better understanding how efforts may be best placed.
format Online
Article
Text
id pubmed-6950931
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-69509312020-01-09 Prioritising the development of severity distributions in burden of disease studies for countries in the European region Wyper, Grant M. A. Grant, Ian Fletcher, Eilidh Chalmers, Neil McCartney, Gerry Stockton, Diane L. Arch Public Health Commentary Severity distributions are a means of summarising the range of health loss suffered to disease which enables estimates of disease occurrence to be paired with disability weights to estimate Years Lost to Disability (YLD) in burden of disease studies. There is a lack of current data exploring severity distributions, which has led to the Global Burden of Disease (GBD) study relying on using the same severity distributions across countries and regions across the world. This is also largely true for some national studies, although there are exceptions. Recent evidence has raised concerns that severity distributions are unlikely to be generalisable as major differences arise when using country-specific data to develop severity distributions. These issues raise uncertainties over interpreting YLD estimates, particularly if they are being used to develop and influence policies and to determine priorities across diseases and populations. It is clear that GBD researchers and those carrying out national studies need to work towards ensuring that estimates are based upon country-specific data, and, if possible, that the impact of assumptions are fully tested and understood. There is a lack of strategy about if, where, and how, this could be achieved, particularly around how efforts should be prioritised. This commentary advocates and presents a possible strategic approach to better understanding how efforts may be best placed. BioMed Central 2020-01-09 /pmc/articles/PMC6950931/ /pubmed/31921418 http://dx.doi.org/10.1186/s13690-019-0385-6 Text en © The Author(s). 2020 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Commentary
Wyper, Grant M. A.
Grant, Ian
Fletcher, Eilidh
Chalmers, Neil
McCartney, Gerry
Stockton, Diane L.
Prioritising the development of severity distributions in burden of disease studies for countries in the European region
title Prioritising the development of severity distributions in burden of disease studies for countries in the European region
title_full Prioritising the development of severity distributions in burden of disease studies for countries in the European region
title_fullStr Prioritising the development of severity distributions in burden of disease studies for countries in the European region
title_full_unstemmed Prioritising the development of severity distributions in burden of disease studies for countries in the European region
title_short Prioritising the development of severity distributions in burden of disease studies for countries in the European region
title_sort prioritising the development of severity distributions in burden of disease studies for countries in the european region
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6950931/
https://www.ncbi.nlm.nih.gov/pubmed/31921418
http://dx.doi.org/10.1186/s13690-019-0385-6
work_keys_str_mv AT wypergrantma prioritisingthedevelopmentofseveritydistributionsinburdenofdiseasestudiesforcountriesintheeuropeanregion
AT grantian prioritisingthedevelopmentofseveritydistributionsinburdenofdiseasestudiesforcountriesintheeuropeanregion
AT fletchereilidh prioritisingthedevelopmentofseveritydistributionsinburdenofdiseasestudiesforcountriesintheeuropeanregion
AT chalmersneil prioritisingthedevelopmentofseveritydistributionsinburdenofdiseasestudiesforcountriesintheeuropeanregion
AT mccartneygerry prioritisingthedevelopmentofseveritydistributionsinburdenofdiseasestudiesforcountriesintheeuropeanregion
AT stocktondianel prioritisingthedevelopmentofseveritydistributionsinburdenofdiseasestudiesforcountriesintheeuropeanregion